Impact of butyrate on PKM2 and HSP90β expression in human colon tissues of different transformation stages: A comparison of gene and protein data

Genes and Nutrition

Volumn 7, Issue 2, 2012, Pages 235-246

  Jahns, Franziska ^a,b   Wilhelm, Anne ^a,b   Greulich, Karl Otto ^b   Mothes, Henning ^c   Radeva, Mariya ^b   Wölfert, Anja ^a   Glei, Michael ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Butyrate; Chemoprevention; Colon cancer; Dietary fiber; HSP90; PKM2

Indexed keywords

BUTYRIC ACID; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 BETA; PYRUVATE KINASE; PYRUVATE KINASE ISOENZYME M 2; UNCLASSIFIED DRUG;

AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER STAGING; CANCER TISSUE; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; HALF LIFE TIME; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PROTEIN DEGRADATION; TISSUE LEVEL; TISSUE SPECIFICITY;

EID: 84860758430     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-011-0254-6     Document Type: Article

References (68)

1. Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA (2008) The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate 68:1773-1789
2. Akalin A, Elmore LW, Forsythe HL, Amaker BA, McCollum ED, Nelson PS, Ware JL, Holt SE (2001) A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. Cancer Res 61:4791-4796 (Pubitemid 32691893)
3. Bali P et al (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 280:26729-26734 (Pubitemid 41040705)
4. Barlow AL, van Drunen CM, Johnson CA, Tweedie S, Bird A, Turner BM (2001) dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res 265:90-103 (Pubitemid 32989067)
5. Basak S, Pookot D, Noonan EJ, Dahiya R (2008) Genistein downregulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. Mol Cancer Ther, 7, 3195-3202.
6. Becker B, Multhoff G, Farkas B, Wild PJ, Landthaler M, Stolz W, Vogt T (2004) Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol 13:27-32 (Pubitemid 38165435)
7. Beere HM (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115:2633-2639 (Pubitemid 41434386)
8. Bingham SA et al (2003) Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361:1496-1501 (Pubitemid 36566339)
9. Borowicki A, Michelmann A, Stein K, Scharlau D, Scheu K, Obst U, Glei M (2011) Fermented wheat aleurone enriched with probiotic strains LGG and Bb12 modulates markers of tumor progression in human colon cells. Nutr Cancer 63:151-160
10. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
11. Brown MA, Zhu L, Schmidt C, Tucker PW (2007) Hsp90-from signal transduction to cell transformation. Biochem Biophys Res Commun 363:241-246 (Pubitemid 47484324)
12. Byun S, Lee KW, Jung SK, Lee EJ, Hwang MK, Lim SH, Bode AM, Lee HJ, Dong Z (2010) Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res 70:2415-2423
13. Cai J, Kirlin WG, Chen Y, Yan X, Jones DP, Sartorelli AC (2006) Overexpression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells. Cell Stress Chaperones 11:199-207 (Pubitemid 44343756)
14. Chen G, Gharib TG, Huang CC et al (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304-313
15. Cho YM, Bae SH, Choi BK, Cho SY, Song CW, Yoo JK, Paik YK (2003) Differential expression of the liver proteome in senescence accelerated mice. Proteomics 3:1883-1894 (Pubitemid 37305882)
16. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC (2008a) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230-233 (Pubitemid 351380249)
17. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC (2008b) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452:181-186 (Pubitemid 351380242)
18. Decaux JF, Antoine B, Kahn A (1989) Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem 264:11584-11590 (Pubitemid 19185323)
19. Diehl MC, Idowu MO, Kimmelshue K, York TP, Elmore LW, Holt SE (2009) Elevated expression of nuclear Hsp90 in invasive breast tumors. Cancer Biol Ther 8:1952-1961
20. Elmore LW, Forsythe R, Forsythe H, Bright AT, Nasim S, Endo K, Holt SE (2008) Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas. Oncol Rep 20:613-617
21. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 28:1601-1613 (Pubitemid 44306128)
22. Fleming SE, Gill R (1997) Aging stimulates fatty acid oxidation in rat colonocytes but does not influence the response to dietary fiber. J Gerontol A Biol Sci Med Sci 52:B318-B330 (Pubitemid 28006995)
23. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D (2008) Comparison of delphinidin, quercetin and (-)-epigallocatechin- 3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Mol Nutr Food Res 52:815-822
24. Greiner EF, Guppy M, Brand K (1994) Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem 269:31484-31490 (Pubitemid 24379505)
25. Guo W, Zhang Y, Chen T, Wang Y, Xue J, Zhang Y, Xiao W, Mo X, Lu Y (2011) Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model. J Cancer Res Clin Oncol 137:65-72
26. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104-119 (Pubitemid 350256609)
27. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
28. Hirsch CL, Smith-Windsor EL, Bonham K (2006) Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. Int J Cancer 118:547-554 (Pubitemid 43076001)
29. Hitosugi T et al (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2:ra73
30. Hofmann C, Obermeier F, Artinger M, Hausmann M, Falk W, Schoelmerich J, Rogler G, Grossmann J (2007) Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology 132:587-600 (Pubitemid 46274657)
31. Jahns F, Wilhelm A, Jablonowski N, Mothes H, Radeva M, Wolfert A, Greulich KO, Glei M (2011) Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue. Carcinogenesis 32:913-920
32. Jones GM, Mayer RJ (1973) Degradation of glucose-metabolizing enzymes in the rat small intestine during starvation. Biochem J 132:657-661
33. Kekatpure VD, Dannenberg AJ, Subbaramaiah K (2009) HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. J Biol Chem 284:7436-7445
34. Kim YS, Milner JA (2011) Bioactive food components and cancerspecific metabonomic profiles. J Biomed Biotechnol 2011:721213
35. Koss K, Maxton D, Jankowski JA (2008) Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention. Colorectal Dis 10:244-248 (Pubitemid 351284676)
36. Lee HM, Greeley GH Jr, Englander EW (2001) Age-associated changes in gene expression patterns in the duodenum and colon of rats. Mech Ageing Dev 122:355-371 (Pubitemid 32193785)
37. Lin K, Rockliffe N, Johnson GG, Sherrington PD, Pettitt AR (2008) Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells. Oncogene 27:2445-2455 (Pubitemid 351521099)
38. Marks PA, Xu WS (2009) Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 107:600-608
39. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300-308 (Pubitemid 41058775)
40. Milicevic Z, Bogojevic D, Mihailovic M, Petrovic M, Krivokapic Z (2008) Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression. Int J Oncol 32:1169-1178
41. Moser C, Lang SA, Kainz S, Gaumann A, Fichtner-Feigl S, Koehl GE, Schlitt HJ, Geissler EK, Stoeltzing O (2007) Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. Mol Cancer Ther 6:2868-2878 (Pubitemid 350206765)
42. Neckers L (2007) Heat shock protein 90: the cancer chaperone. J Biosci 32:517-530 (Pubitemid 46708702)
43. O'Connell K, Gannon J, Doran P, Ohlendieck K (2007) Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int J Mol Med 20:145-153
44. Pearl LH, Prodromou C, Workman P (2008) The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 410:439-453 (Pubitemid 351429015)
45. Peipins LA, Sandler RS (1994) Epidemiology of colorectal adenomas. Epidemiol Rev 16:273-297
46. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
47. Picard D (2011) HSP90 interactors. http://www.picard.ch/downloads/ Hsp90interactors.pdf. Accessed 16 June 2011
48. Poole GP, Bloxham DP (1982) The turnover of L-type pyruvate kinase in cultured rat hepatocytes. Biochem J 204:89-95
49. Pool-Zobel BL, Selvaraju V, Sauer J, Kautenburger T, Kiefer J, Richter KK, Soom M, Wolfl S (2005) Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 26:1064-1076 (Pubitemid 41214299)
50. Radeva M (2009) Expression analysis of a selected gene set in malignant and non-malignant tissues derived from individuals with colon cancer. Comparison with protein expression data. Dissertation, University of Jena
51. Rahmani M, Yu C, Dai Y, Reese E, Ahmed W, Dent P, Grant S (2003) Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. Cancer Res 63:8420-8427 (Pubitemid 37549498)
52. Rashmi R, Santhosh Kumar TR, Karunagaran D (2003) Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 538:19-24 (Pubitemid 36287418)
53. Rogler G, Daig R, Aschenbrenner E, Vogl D, Schlottmann K, Falk W, Gross V, Schölmerich J, Andus T (1998) Establishment of longterm primary cultures of human small and large intestinal epithelial cells. Lab Invest 78:889-890 (Pubitemid 28347886)
54. Sauer J, Richter KK, Pool-Zobel BL (2007) Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. Br J Nutr 97:928-937 (Pubitemid 46554408)
55. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682:39-53
56. Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W (2008) Isotypespecific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation. Int J Cancer 123:312-321 (Pubitemid 351842015)
57. Thangaraju M, Carswell KN, Prasad PD, Ganapathy V (2009) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J 417:379-389
58. Tran PL, Kim SA, Choi HS, Yoon JH, Ahn SG (2010) Epigallocatechin- 3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer 10:276
59. Traxinger RR, Marshall S (1992) Insulin regulation of pyruvate kinase activity in isolated adipocytes. Crucial role of glucose and the hexosamine biosynthesis pathway in the expression of insulin action. J Biol Chem 267:9718-9723
60. Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537-549
61. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
62. Wolever TM, Chiasson JL (2000) Acarbose raises serum butyrate in human subjects with impaired glucose tolerance. Br J Nutr 84:57-61 (Pubitemid 30611669)
63. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40:235-243 (Pubitemid 44309560)
64. Yamada K, Noguchi T (1999) Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J 337(Pt 1):1-11 (Pubitemid 29039075)
65. Yin Z, Henry EC, Gasiewicz TA (2009) (-)-Epigallocatechin-3- gallate is a novel Hsp90 inhibitor. Biochemistry 48:336-345
66. Zhang Y, Zhou L, Bao YL, Wu Y, Yu CL, Huang YX, Sun Y, Zheng LH, Li YX (2010) Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact 185:174-181
67. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P (1999) Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA 96:1291-1296 (Pubitemid 29098444)
68. Zwerschke W, Mazurek S, Stockl P, Hutter E, Eigenbrodt E, Jansen- Durr P (2003) Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem J 376:403-411 (Pubitemid 38010525)